144 related articles for article (PubMed ID: 34912631)
1. Hodgkin's Lymphoma in the Context of Psoriasis Vulgaris Treated With Immunosuppressive Therapy: A Case Report and Review of Literature.
Alali Z; Al Ashour BH; Alrefaee M
Cureus; 2021 Nov; 13(11):e19490. PubMed ID: 34912631
[TBL] [Abstract][Full Text] [Related]
2. Casual or Causal? Two Unique Cases of Hodgkin's Lymphoma: A Case Report and Literature Review.
Malik F; Ali N; Jafri SIM; Fidler C
Am J Case Rep; 2017 May; 18():553-557. PubMed ID: 28522794
[TBL] [Abstract][Full Text] [Related]
3. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
6. Skin as the primary site of Hodgkin's disease: a case report of primary cutaneous Hodgkin's disease and review of its relationship with non-Hodgkin's lymphoma.
Guitart J; Fretzin D
Am J Dermatopathol; 1998 Apr; 20(2):218-22. PubMed ID: 9557796
[TBL] [Abstract][Full Text] [Related]
7. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
Khalidi HS; Singleton TP; Weiss SW
Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
[TBL] [Abstract][Full Text] [Related]
9. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Tsurumi H; Takahashi T; Moriwaki H; Muto Y
Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
[TBL] [Abstract][Full Text] [Related]
10. Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?
Bebb JR; Logan RP
Aliment Pharmacol Ther; 2001 Dec; 15(12):1843-9. PubMed ID: 11736713
[TBL] [Abstract][Full Text] [Related]
11. Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.
O'Connor OA; Lue JK; Sawas A; Amengual JE; Deng C; Kalac M; Falchi L; Marchi E; Turenne I; Lichtenstein R; Rojas C; Francescone M; Schwartz L; Cheng B; Savage KJ; Villa D; Crump M; Prica A; Kukreti V; Cremers S; Connors JM; Kuruvilla J
Lancet Oncol; 2018 Feb; 19(2):257-266. PubMed ID: 29276022
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's lymphoma in a patient on adalimumab treatment for psoriasis.
Alballa N; Alyousef A; Alamari A; Alhumidi AA; Zayed MA; Zeitouni L; Alsaif FM
AME Case Rep; 2018; 2():49. PubMed ID: 30701218
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Hodgkin's disease.
Introcaso CE; Kantor J; Porter DL; Junkins-Hopkins JM
J Am Acad Dermatol; 2008 Feb; 58(2):295-8. PubMed ID: 18222326
[TBL] [Abstract][Full Text] [Related]
14. [Non-Hodgkin's lymphoma and pustular psoriasis: a case report].
Jaber K; Hammami H; Youssef S; Dhaoui MR; Doss N
Rev Med Interne; 2009 Aug; 30(8):717-9. PubMed ID: 19403211
[TBL] [Abstract][Full Text] [Related]
15. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study.
Locatelli F; Mauz-Koerholz C; Neville K; Llort A; Beishuizen A; Daw S; Pillon M; Aladjidi N; Klingebiel T; Landman-Parker J; Medina-Sanson A; August K; Sachs J; Hoffman K; Kinley J; Song S; Song G; Zhang S; Suri A; Gore L
Lancet Haematol; 2018 Oct; 5(10):e450-e461. PubMed ID: 30290902
[TBL] [Abstract][Full Text] [Related]
16. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
Lavey RS; Eby NL; Prosnitz LR
Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
Corazza M; Zampino MR; Montanari A; Altieri E; Virgili A
Dermatology; 2003; 206(4):330-3. PubMed ID: 12771475
[TBL] [Abstract][Full Text] [Related]
18. Development of non-Hodgkin's lymphoma in a patient with primary biliary cirrhosis: A case report and review of the literature.
Kanellopoulou T; Alexopoulou A; Kontopidou FN; Filiotou A
Ann Gastroenterol; 2011; 24(2):125-128. PubMed ID: 24713720
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
[TBL] [Abstract][Full Text] [Related]
20. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry.
Rüdiger T; Ott G; Ott MM; Müller-Deubert SM; Müller-Hermelink HK
Am J Surg Pathol; 1998 Oct; 22(10):1184-91. PubMed ID: 9777980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
